The impact of low input DNA on the reliability of DNA methylation as measured by the Illumina Infinium MethylationEPIC BeadChip.

DNA input DNA methylation Illumina Infinium MethylationEPIC BeadChip low DNA reliability

Journal

Epigenetics
ISSN: 1559-2308
Titre abrégé: Epigenetics
Pays: United States
ID NLM: 101265293

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 15 10 2022
medline: 15 11 2022
entrez: 14 10 2022
Statut: ppublish

Résumé

DNA methylation (DNAm) is commonly assayed using the Illumina Infinium MethylationEPIC BeadChip, but there is currently little published evidence to define the lower limits of the amount of DNA that can be used whilst preserving data quality. Such evidence is valuable for analyses utilizing precious or limited DNA sources. We used a single pooled sample of DNA in quadruplicate at three dilutions to define replicability and noise, and an independent population dataset of 328 individuals (from a community-based study including US-born non-Hispanic Black and white persons) to assess the impact of total DNA input on the quality of data generated using the Illumina Infinium MethylationEPIC BeadChip. We found that data are less reliable and more noisy as DNA input decreases to 40ng, with clear reductions in data quality; and that low DNA input is associated with a reduction in power to detect EWAS associations, requiring larger sample sizes. We conclude that DNA input as low as 40ng can be used with the Illumina Infinium MethylationEPIC BeadChip, provided quality checks and sensitivity analyses are undertaken.

Identifiants

pubmed: 36239035
doi: 10.1080/15592294.2022.2123898
pmc: PMC9665153
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2366-2376

Subventions

Organisme : NIMHD NIH HHS
ID : R01 MD014304
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG027122
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom

Références

Eur J Epidemiol. 2022 Apr;37(4):377-387
pubmed: 34651232
PLoS One. 2011;6(11):e27636
pubmed: 22125618
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Wellcome Open Res. 2022 Feb 4;7:41
pubmed: 35592546
Epigenomes. 2021 Feb 19;5(1):6
pubmed: 33777442
Epigenetics. 2021 May;16(5):495-502
pubmed: 32749174
Epigenetics. 2022 Dec;17(12):1636-1645
pubmed: 35356867
Clin Epigenetics. 2021 Feb 16;13(1):36
pubmed: 33593402
Acta Neuropathol. 2013 Jun;125(6):913-6
pubmed: 23670100
Circ Cardiovasc Genet. 2016 Oct;9(5):436-447
pubmed: 27651444
Sci Rep. 2016 Jul 26;6:30317
pubmed: 27457678
Epigenetics. 2018;13(1):19-32
pubmed: 29381404
Elife. 2020 May 05;9:
pubmed: 32367804
Bioinformatics. 2018 Dec 1;34(23):3983-3989
pubmed: 29931280
Biol Psychiatry. 2019 May 15;85(10):838-849
pubmed: 30905381
Biol Res Nurs. 2018 Mar;20(2):145-152
pubmed: 29258399

Auteurs

Sarah Holmes Watkins (SH)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Karen Ho (K)

Bristol Bioresource Laboratories, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Christian Testa (C)

Department of Social and Behavioral Sciences, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.

Louise Falk (L)

Integrative Cancer Epidemiology Programme (ICEP), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Patrice Soule (P)

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Linda V Nguyen (LV)

Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Sophie FitzGibbon (S)

Bristol Bioresource Laboratories, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Catherine Slack (C)

Bristol Bioresource Laboratories, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Jarvis T Chen (JT)

Department of Social and Behavioral Sciences, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.

George Davey Smith (G)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Immaculata De Vivo (I)

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Andrew J Simpkin (AJ)

School of Medicine, National University of Ireland Galway, Galway, Ireland.

Kate Tilling (K)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Pamela D Waterman (PD)

Department of Social and Behavioral Sciences, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.

Nancy Krieger (N)

Department of Social and Behavioral Sciences, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.

Matthew Suderman (M)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Caroline Relton (C)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH